Tower Research Capital »

Mymd Pharmaceuticals shares owned by Tower Research Capital

Quarter-by-quarter ownership of Mymd Pharmaceuticals (TNFA) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Mymd Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Mymd Pharmaceuticals held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mymd Pharmaceuticals by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $72 39 1.85

More positions owned by Tower Research Capital

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Costco Wholesale Corporation (COST)
Netflix (NFLX)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Adobe Systems Incorporated (ADBE)

View all positions for Tower Research Capital

Top funds holding Mymd Pharmaceuticals

Geode Capital Management
Vanguard Group
Virtu Financial
BlackRock
BlackRock
Parallel Advisors
Group One Trading
Morgan Stanley
Wells Fargo & Company
Sandy Spring Bank
Advisor Group Holdings
Harbor Investment Advisory
Royal Bank of Canada
Tower Research Capital
ORG Wealth Partners

View all funds holding Mymd Pharmaceuticals